关注
Anna Calkin
Anna Calkin
Baker Heart and Diabetes Institute
在 baker.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
AC Calkin, P Tontonoz
Nature reviews Molecular cell biology 13 (4), 213-224, 2012
8052012
Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail
D Brasacchio, J Okabe, C Tikellis, A Balcerczyk, P George, EK Baker, ...
Diabetes 58 (5), 1229-1236, 2009
6012009
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
A Soro-Paavonen, AMD Watson, J Li, K Paavonen, A Koitka, AC Calkin, ...
Diabetes 57 (9), 2461-2469, 2008
4982008
Liver x receptor signaling pathways and atherosclerosis
AC Calkin, P Tontonoz
Arteriosclerosis, thrombosis, and vascular biology 30 (8), 1513-1518, 2010
3652010
Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E–deficient mice
P Lewis, N Stefanovic, J Pete, AC Calkin, S Giunti, V Thallas-Bonke, ...
Circulation 115 (16), 2178-2187, 2007
2682007
Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux
AC Calkin, BG Drew, A Ono, SJ Duffy, MV Gordon, SM Schoenwaelder, ...
Circulation 120 (21), 2095-2104, 2009
2522009
FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption
BL Clifford, LR Sedgeman, KJ Williams, P Morand, A Cheng, KE Jarrett, ...
Cell metabolism 33 (8), 1671-1684. e4, 2021
2272021
Reactive oxygen species can provide atheroprotection via NOX4-dependent inhibition of inflammation and vascular remodeling
SP Gray, E Di Marco, K Kennedy, P Chew, J Okabe, A El-Osta, AC Calkin, ...
Arteriosclerosis, thrombosis, and vascular biology 36 (2), 295-307, 2016
1902016
Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects
AC Calkin, JM Forbes, CM Smith, M Lassila, ME Cooper, ...
Arteriosclerosis, thrombosis, and vascular biology 25 (9), 1903-1909, 2005
1792005
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products
M Lassila, KK Seah, TJ Allen, V Thallas, MC Thomas, R Candido, ...
Journal of the American Society of Nephrology 15 (8), 2125-2138, 2004
1622004
Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice
M Lassila, K Jandeleit-Dahm, KK Seah, CM Smith, AC Calkin, TJ Allen, ...
Journal of the American Society of Nephrology 16 (2), 363-373, 2005
1432005
PPAR-α and-γ agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse
AC Calkin, S Giunti, KA Jandeleit-Dahm, TJ Allen, ME Cooper, ...
Nephrology Dialysis Transplantation 21 (9), 2399-2405, 2006
1332006
An integrative systems genetic analysis of mammalian lipid metabolism
BL Parker, AC Calkin, MM Seldin, MF Keating, EJ Tarling, P Yang, ...
Nature 567 (7747), 187-193, 2019
1172019
Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation
AC Calkin, ME Cooper, KA Jandeleit-Dahm, TJ Allen
Diabetologia 49, 766-774, 2006
1002006
The IDOL–UBE2D complex mediates sterol-dependent degradation of the LDL receptor
L Zhang, L Fairall, BT Goult, AC Calkin, C Hong, CJ Millard, P Tontonoz, ...
Genes & development 25 (12), 1262-1274, 2011
962011
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice
AMD Watson, A Soro-Paavonen, K Sheehy, J Li, AC Calkin, A Koitka, ...
Diabetologia 54, 681-689, 2011
872011
Estrogen receptor (ER) α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression
BG Drew, H Hamidi, Z Zhou, CJ Villanueva, SA Krum, AC Calkin, ...
Journal of Biological Chemistry 290 (9), 5566-5581, 2015
782015
The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of …
AC Calkin, S Giunti, KJ Sheehy, C Chew, V Boolell, YS Rajaram, ...
Diabetologia 51, 1731-1740, 2008
762008
Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy
RH Ritchie, EJ Zerenturk, D Prakoso, AC Calkin
Journal of molecular endocrinology 58 (4), R225-R240, 2017
742017
FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors
AC Calkin, BT Goult, L Zhang, L Fairall, C Hong, JWR Schwabe, ...
Proceedings of the National Academy of Sciences 108 (50), 20107-20112, 2011
702011
系统目前无法执行此操作,请稍后再试。
文章 1–20